18 - 64 y (N = 167,647) | ≤30 days from initial COVID19 Dx | 31 - 90 days from initial COVID19 Dx | 91 - 180 days from initial COVID19 Dx | 181 - 240 days from initial COVID19 Dx | 241 - 300 days from initial COVID19 Dx | 301 - 360 days from initial COVID19 Dx | ||||||

Total unique patients with ≥1 COVID19 Dx | 36,280 | 21.64% | 10,648 | 6.35% | 6817 | 4.07% | 3506 | 2.09% | 2404 | 1.43% | 1669 | 1.00% |

MA65+ (N = 69,903) | ≤30 days from initial COVID19 Dx | 31 - 90 days from initial COVID19 Dx | 91 - 180 days from initial COVID19 Dx | 181 - 240 days from initial COVID19 Dx | 241 - 300 days from initial COVID19 Dx | 301 - 360 days from initial COVID19 Dx | ||||||

Total unique patients with ≥1 COVID19 Dx | 18,330 | 26.22% | 7445 | 10.65% | 4346 | 6.22% | 2242 | 3.21% | 1500 | 2.15% | 976 | 1.40% |